Cargando…

Mesenchymal Stem Cell-Derived Extracellular Vesicles for Osteoarthritis Treatment: Extracellular Matrix Protection, Chondrocyte and Osteocyte Physiology, Pain and Inflammation Management

Osteoarthritis (OA) is a common degenerative disease that can lead to persistent pain and motion restriction. In the last decade, stem cells, particularly mesenchymal stem cells (MSCs), have been explored as a potential alternative OA therapy due to their regenerative capacity. Furthermore, it has b...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Thu Huyen, Duong, Chau Minh, Nguyen, Xuan-Hung, Than, Uyen Thi Trang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616200/
https://www.ncbi.nlm.nih.gov/pubmed/34831109
http://dx.doi.org/10.3390/cells10112887
_version_ 1784604289280245760
author Nguyen, Thu Huyen
Duong, Chau Minh
Nguyen, Xuan-Hung
Than, Uyen Thi Trang
author_facet Nguyen, Thu Huyen
Duong, Chau Minh
Nguyen, Xuan-Hung
Than, Uyen Thi Trang
author_sort Nguyen, Thu Huyen
collection PubMed
description Osteoarthritis (OA) is a common degenerative disease that can lead to persistent pain and motion restriction. In the last decade, stem cells, particularly mesenchymal stem cells (MSCs), have been explored as a potential alternative OA therapy due to their regenerative capacity. Furthermore, it has been shown that trophic factors enveloped in extracellular vesicles (EVs), including exosomes, are a crucial aspect of MSC-based treatment for OA. Evidently, EVs derived from different MSC sources might rescue the OA phenotype by targeting many biological processes associated with cartilage extracellular matrix (ECM) degradation and exerting protective effects on different joint cell types. Despite this advancement, different studies employing EV treatment for OA have revealed reverse outcomes depending on the EV cargo, cell source, and pathological condition. Hence, in this review, we aim to summarize and discuss the possible effects of MSC-derived EVs based on recent findings at different stages of OA development, including effects on cartilage ECM, chondrocyte biology, osteocytes and bone homeostasis, inflammation, and pain management. Additionally, we discuss further strategies and technical advances for manipulating EVs to specifically target OA to bring the therapy closer to clinical use.
format Online
Article
Text
id pubmed-8616200
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86162002021-11-26 Mesenchymal Stem Cell-Derived Extracellular Vesicles for Osteoarthritis Treatment: Extracellular Matrix Protection, Chondrocyte and Osteocyte Physiology, Pain and Inflammation Management Nguyen, Thu Huyen Duong, Chau Minh Nguyen, Xuan-Hung Than, Uyen Thi Trang Cells Review Osteoarthritis (OA) is a common degenerative disease that can lead to persistent pain and motion restriction. In the last decade, stem cells, particularly mesenchymal stem cells (MSCs), have been explored as a potential alternative OA therapy due to their regenerative capacity. Furthermore, it has been shown that trophic factors enveloped in extracellular vesicles (EVs), including exosomes, are a crucial aspect of MSC-based treatment for OA. Evidently, EVs derived from different MSC sources might rescue the OA phenotype by targeting many biological processes associated with cartilage extracellular matrix (ECM) degradation and exerting protective effects on different joint cell types. Despite this advancement, different studies employing EV treatment for OA have revealed reverse outcomes depending on the EV cargo, cell source, and pathological condition. Hence, in this review, we aim to summarize and discuss the possible effects of MSC-derived EVs based on recent findings at different stages of OA development, including effects on cartilage ECM, chondrocyte biology, osteocytes and bone homeostasis, inflammation, and pain management. Additionally, we discuss further strategies and technical advances for manipulating EVs to specifically target OA to bring the therapy closer to clinical use. MDPI 2021-10-26 /pmc/articles/PMC8616200/ /pubmed/34831109 http://dx.doi.org/10.3390/cells10112887 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Nguyen, Thu Huyen
Duong, Chau Minh
Nguyen, Xuan-Hung
Than, Uyen Thi Trang
Mesenchymal Stem Cell-Derived Extracellular Vesicles for Osteoarthritis Treatment: Extracellular Matrix Protection, Chondrocyte and Osteocyte Physiology, Pain and Inflammation Management
title Mesenchymal Stem Cell-Derived Extracellular Vesicles for Osteoarthritis Treatment: Extracellular Matrix Protection, Chondrocyte and Osteocyte Physiology, Pain and Inflammation Management
title_full Mesenchymal Stem Cell-Derived Extracellular Vesicles for Osteoarthritis Treatment: Extracellular Matrix Protection, Chondrocyte and Osteocyte Physiology, Pain and Inflammation Management
title_fullStr Mesenchymal Stem Cell-Derived Extracellular Vesicles for Osteoarthritis Treatment: Extracellular Matrix Protection, Chondrocyte and Osteocyte Physiology, Pain and Inflammation Management
title_full_unstemmed Mesenchymal Stem Cell-Derived Extracellular Vesicles for Osteoarthritis Treatment: Extracellular Matrix Protection, Chondrocyte and Osteocyte Physiology, Pain and Inflammation Management
title_short Mesenchymal Stem Cell-Derived Extracellular Vesicles for Osteoarthritis Treatment: Extracellular Matrix Protection, Chondrocyte and Osteocyte Physiology, Pain and Inflammation Management
title_sort mesenchymal stem cell-derived extracellular vesicles for osteoarthritis treatment: extracellular matrix protection, chondrocyte and osteocyte physiology, pain and inflammation management
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616200/
https://www.ncbi.nlm.nih.gov/pubmed/34831109
http://dx.doi.org/10.3390/cells10112887
work_keys_str_mv AT nguyenthuhuyen mesenchymalstemcellderivedextracellularvesiclesforosteoarthritistreatmentextracellularmatrixprotectionchondrocyteandosteocytephysiologypainandinflammationmanagement
AT duongchauminh mesenchymalstemcellderivedextracellularvesiclesforosteoarthritistreatmentextracellularmatrixprotectionchondrocyteandosteocytephysiologypainandinflammationmanagement
AT nguyenxuanhung mesenchymalstemcellderivedextracellularvesiclesforosteoarthritistreatmentextracellularmatrixprotectionchondrocyteandosteocytephysiologypainandinflammationmanagement
AT thanuyenthitrang mesenchymalstemcellderivedextracellularvesiclesforosteoarthritistreatmentextracellularmatrixprotectionchondrocyteandosteocytephysiologypainandinflammationmanagement